Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Biofrontera (BFRI)
Marpai (MRAI)
Cingulate, Inc. (CING)
Stronghold Digital Mining, Inc. (SDIG)
Enfusion, Inc. (ENFN)
Portillos Inc. (PTLO)
Winc, Inc. (BEV)
The Vita Coco Company, Inc. (COCO)
P10, Inc. (PX)
Ventyx Biosciences, Inc. (VTYX)
Winc, Inc. (WBEV)
Runway Growth Finance Corp (RWAY)
Aris Water Solutions, Inc. (ARIS)
Minerva Surgical, Inc (UTRS)
Xilio Therapeutics, Inc. (XLO)
Informatica Inc. (INFA)
Arteris, Inc. (AIP)
Priced IPO
Mink Therapeutics, Inc. (INKT)
Paragon 28, Inc. (FNA)
Ihs Holding Limited (IHS)
Gitlab Inc. (GTLB)
Lucid Diagnostics, Inc. (LUCD)
Healthcare Triangle (HCTI)
AvidXchange (AVDX)
Cognition Therapeutics, Inc. (CGTX)
Isoplexis Corporation (ISO)
Pyxis Oncology, Inc. (PYXS)
Life Time Group Holdings, Inc. (LTH)
Theseus Pharmaceuticals, Inc. (THRX)
Tricon Residential (TCN)
Volcon (VLCN)
Nuvei (NVEI)
Tdcx, Inc. (TDCX)
First Watch Restaurant Group, Inc. (FWRG)
Exscientia Limited (EXAI)
Warby Parker (WRBY)
Olaplex Holdings Inc. (OLPX)
More companies

Omega Therapeutics Inc. (OMGA)

Sector - Healthcare

Price chart

+26.59%
Return from IPO

Company News

IPO Profile

About company

Company Logo
At Omega Therapeutics, their goal is to pioneer a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to fundamentally transform human medicine in the service of patients. Their pioneering OMEGA Epigenomic Programming platform is designed to coopt nature’s universal operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. They have deciphered the three-dimensional architecture of the human genome and its accompanying regulators, which are organized into distinct and evolutionarily conserved structures called Insulated Genomic Domains, or IGDs. IGDs are the fundamental structural and functional units of gene control and cell differentiation and act as the “control room” of biology. Most diseases are caused by aberrant gene expression rooted in alterations in IGDs. The OMEGA platform has enabled them to systematically identify and validate thousands of novel DNA-sequence-based epigenomic “zip codes” within IGDs. They call these epigenomic targets EpiZips. They rationally design and engineer modular, programmable mRNA-encoded epigenetic medicines, which they call Omega Epigenomic Controllers, or OECs, to target EpiZips for Precision Genomic Control. This enables them to precisely tune genes to a desired level of expression and to control the duration of expression. Through this approach, they believe that the OMEGA platform has broad potential applicability across a range of diseases and conditions.
Industry
Biological Products (no Diagnostic Substances)
CEO CFO
Mahesh Karande Roger Sawhney
Employees Founded
65 2016

Contacts

Address: 20 Acorn Park Drive, Cambridge, Ma 02140. Us

Telephone: 617-949-4360.

Web page: http://omegatherapeutics.com

IPO information

First Trade Date 7/30/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 7.4
Shares Revised (MM) 7.4
Expected offer amount (MM) $125.8
Realized offer amount(MM) $125.8

Financial Data (last reporting year)

Market Cap (MM) $794.3
Revenues (MM) $0
Net Income (Loss) (MM) $-37.5

Voting

What do you think will happen with the OMGA share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Goldman Sachs

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Goldman Sachs/ Jefferies/ Piper Sandler
CO-Managers
Wedbush PacGrow

Sector: Healthcare

Tweets about $OMGA

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats